发明名称 BIOMARKERS FOR DIAGNOSING ALZHEIMER'S DISEASE
摘要 <p>A method for assessing the state of Alzheimer's disease in patients is disclosed. A method for monitoring the progression of Alzheimer's disease in patients is also disclosed. The method applies detection of specific markers in body fluids (e.g. CSF), using mass spectrometric analysis (SELDI-TOF MS). The specific markers are: human cystatin C, human beta-2-microglobulin, human myoglobin neurosecretory protein VGF or fragments of these proteins.</p>
申请公布号 CA2496321(E) 申请公布日期 2004.03.04
申请号 CA20032496321 申请日期 2003.08.11
申请人 BAYER HEALTHCARE AG 发明人 YALKINOGLU, OEZKAN;KOENIG, GERHARD;HOCHSTRASSER, DENIS FRANCOIS;SANCHEZ, JEAN-CHARLES;CARRETTE, ODILE
分类号 G01N27/62;G01N33/68;C07K14/47;C07K14/74;C07K14/805;C07K14/81;C12Q1/37;G01N33/53 主分类号 G01N27/62
代理机构 代理人
主权项
地址